Peripheral Neuropathy: Clinical Trials

8 trials for Peripheral Neuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 recruiting, 1 unknown. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 4, Terminated 2, Recruiting 1, Unknown 1

Follow Peripheral Neuropathy: new trials by email Literature Review of Peripheral Neuropathy trials Research Report on Peripheral Neuropathy

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)
Bortezomib + Lenalidomide + Dexamethasone + Fenofibrate 160 mg tablet, Bortezomib + Lenalidomide + Dexamethasone - Peripheral Neuropathy, Multiple Myeloma, Neoplasms
Phase 4RecruitingTanta University442025-08-302025-11-04
IVIg for Demyelination in Diabetes Mellitus
10% intravenous immunoglobulin (IVIg), 0.9% sodium chloride - Peripheral Neuropathy, Diabetes Mellitus
Phase 4UnknownUniversity of Toronto252015-02-012016-11-11
Tapentadol Versus Oxycodone - a Mechanism-based Treatment Approach in Neuropathic Pain
tapentadol, oxycodone - Peripheral Neuropathy
Phase 4TerminatedUniversity Hospital Schleswig-Holstein32011-10-012025-01-07
Intrathecal Bolus Doses of Ziconotide
Ziconotide - Peripheral Neuropathy
Phase 4CompletedUniversity Hospital, Linkoeping262011-08-012014-12-30
Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109)
Mecobalamin IV Injection, Mecobalamin IM injection, Mecobalamin IV or IM injection - Peripheral Neuropathy
Phase 4CompletedEisai Co., Ltd.10722010-04-012012-11-07
Spinal Cord Stimulation for Painful Diabetic Neuropathy
Precision Spinal Cord Stimulation - Diabetic Neuropathy, Pain
Phase 4TerminatedBoston Scientific Corporation12007-02-012012-03-13
Evaluation of the Efficacy of Cesametâ„¢ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy
Cesametâ„¢ (nabilone) - Peripheral Neuropathy, Antineoplastic Combined Chemotherapy Protocols
Phase 4CompletedNEMA Research, Inc.232006-10-012008-02-15
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Placebo Capsules + Placebo Patch, Placebo capsules + Lidoderm®, Gabapentin + Placebo - Postherpetic Neuralgia, Diabetic Neuropathy
Phase 4CompletedEndo USA Inc., a Keenova Therapeutics Company622003-01-012024-01-02

Narrower conditions

Peripheral Nervous System Diseases (8)  ·  Diabetic Neuropathies (3)  ·  Neoplasms (2)  ·  Neuralgia (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Carpal Tunnel Syndrome (1)  ·  Complex Regional Pain Syndromes (1)  ·  Diabetes Mellitus (1)  ·  Lymphoma, Follicular (1)  ·  Multiple Myeloma (1)  ·  Neuralgia, Postherpetic (1)  ·  Pain (1)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)  ·  Wounds and Injuries (1)

Broader conditions

Nervous System Diseases (8)  ·  Neuromuscular Diseases (8)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Endocrine System Diseases (4)  ·  Neurologic Manifestations (4)  ·  Signs and Symptoms (4)  ·  Diabetes Complications (3)  ·  Diabetes Mellitus (3)  ·  Immune System Diseases (3)  ·  Pain (3)  ·  Hemic and Lymphatic Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms by Histologic Type (2)  ·  Autoimmune Diseases (1)

Interventions

Bortezomib (1)  ·  Dexamethasone (1)  ·  Fenofibrate (1)  ·  Gabapentin (1)  ·  Immunoglobulins, Intravenous (1)  ·  Injections, Intramuscular (1)  ·  Lenalidomide (1)  ·  Lidocaine (1)  ·  Lidoderm (1)  ·  Oxycodone (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Tablets (1)  ·  Tapentadol (1)  ·  nabilone (1)

Sponsors

Boston Scientific Corporation (1)  ·  Eisai Co., Ltd. (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  NEMA Research, Inc. (1)  ·  Tanta University (1)  ·  University Hospital Schleswig-Holstein (1)  ·  University Hospital, Linkoeping (1)  ·  University of Toronto (1)

Countries

United States (3)  ·  Canada (1)  ·  China (1)  ·  Egypt (1)  ·  Germany (1)  ·  Sweden (1)

Top investigators

Ari Breiner, MD, FRCPC (1)  ·  Ashraf M Alaa, BSc of clinical pharmacy (1)  ·  Charlotte A Richmond, PhD (1)  ·  Francis McDonnell, MD (1)  ·  Joseph V Pergolizzi, MD (1)  ·  Jvming Lu (1)  ·  Ralf Baron, Prof. Dr. (1)

Results publications

PMID 33522900